Patent Prior Approval Analysis In Brazil – ANVISA’ s Role Clarified
By Karina Daiha Four recently published Guidelines shed light on ANVISA’s procedures related to prior approval analysis of patent applications. In November 2020, the Brazilian Health Surveillance Agency (Brazilian FDA – “ANVISA”) published four guidelines disclosing the procedures adopted by ANVISA to analyze prior approval of patent applications related to pharmaceutical products and processes. This is […]
Brazilian PTO On Track To Join World’s Leading Patent Offices
by Louis Lozouet In our previous article on May 15, 2020, we discussed the “Brazilian Patent and Trademark Office (BRPTO) Plan To Combat Patent Backlog in Brazil“. The purpose of this article is to summarize other initiatives that the BRPTO has been implementing over the past year, in order to become more efficient and attempt […]
IP and Tax Incentives for Innovation: tools to maximize investments in R&D
By Louis Lozouet The framework of innovation in Brazil The purpose of this article is to show that tax incentive policies fostering innovation and the Intellectual Property (IP) system complement each other and together could be used more efficiently in order to boost R&D in Brazil. Brazil still appears in median positions in innovation rankings. […]
Covid-19 in Brazil: A Brazilian Scientist’s Perspective
By Karina Daiha (This article was first published on Mondaq on 4 June, and transcribes the interview conducted with Dr. Átila Duque Rossi, PhD, from the Molecular Virology Laboratory of the Federal University of Rio de Janeiro (UFRJ) on May 17, 2020) On March 11, 2020, the World Health Organization characterized COVID-19, a disease caused […]
BRPTO Takes Initiatives in Fight Against COVID-19
By Karina Daiha and Julian Cornelius Since the arrival of the new Coronavirus in Brazil, the BRPTO has adopted several measures to assist in fighting the pandemic. These initiatives include preventing the spread of the virus, providing information on technologies related to the diagnostic and treatment of COVID-19, as well as prioritising patent applications of […]
An update on the BRPTO’s plan to combat patent backlog in Brazil
By Andre Venturini Backlog is the first word that comes to an applicant’s mind when considering Brazil for patent filings. Indeed, at its worst, official statistics indicated an average pendency time of 10,9 years at the Brazilian Patent Office (INPI) from filing of a patent application to patent grant. This is still by far the […]
The Use of Patents by Brazilian Start-Ups
By Julian Cornelius Over the last years, Brazil has significantly invested in its start-up industry. This can be seen in the creation of incubators, accelerators, technology parks, grant programs and financing. Indeed, since 2018, Brazil has a number of so called “Unicorn” start–ups, among them 99 Taxis, Nubank, PagSeguro, Stone, Movile, and iFood. In a […]
Update on Brazilian Biotech Patent Activity
By Karina Daiha and Andre Venturini In a recent article, we analysed a study by the Brazilian Patent Office (INPI) on the categorization of biotechnology patent documents based on international patent classification, also presenting an analysis of patent filing in this sector in Brazil between 2012 and 2016. Last week, a new study was released by […]
PPH Pilot Project with JPO Renewed
By Julian Cornelius On 12 February, by Rule235/2019, the INPI (the Brazilian Patent Office) initiated Phase II of the Patent Prosecution Highway (PPH) Pilot Project with the Japan Patent Office (JPO). The project allows for fast-track patent examination procedures and the sharing of information regarding examinations in both offices. The INPI released the provisional results […]
Exercise Hormone May Prevent Alzheimer’s
Irisin and the patentability of new methods for treating diseases in Brazil By Karina Daiha New research led by Brazilian scientists has indicated a relationship between levels of the hormone – irisin – produced by muscles in response to exercise and Alzheimer’s disease (AD). The study was published earlier this month in one of the […]
